BioSpace News Archive

Policy

Now Recruiting Patients for a New FDA Oversight Trial Evaluating the Use of a Patient’s Own Fat Tissue for the Treatment of Post-COVID-19 Lung Damage

Tulip Medical has sponsored and funded a new FDA Oversight Trial that seeks to restore respiratory function in adults who have suffered lung damage from the COVID-19 virus.

November 17, 2020
·
3 min read
Biotech Beach

XPRIZE and Cognizant Announce Pandemic Response Challenge to Safely Reopen Societies and Restart Economies Around the World

New $500K, four-month competition aims to accelerate use of artificial intelligence to minimize coronavirus infection cases while reducing the economic cost of lockdowns

November 17, 2020
·
6 min read
Drug Development

Bayer Presents FIDELIO-DKD Phase III Study Cardiovascular Subgroup Analysis of Patients With Chronic Kidney Disease and Type 2 Diabetes

Late-breaking data presented at AHA 2020 Scientific Sessions and published simultaneously in Circulation

November 17, 2020
·
10 min read
Itamar Medical Announces Preliminary Results from Two Large Claims Database Studies Demonstrating Significant Health Economic Benefits of Effective Sleep Apnea Management for Cardiovascular Patients

Initial findings show potential for material short-term annual savings of up to $5,000 per cardiovascular patient when treated for sleep apnea

November 17, 2020
·
6 min read
Business

NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 - Has Sufficient Cash, Coronavirus Drug Development Progress

NanoViricides, Inc. a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, has filed its quarterly report for its first quarter of financial year 2021 with the Securities and Exchange Commission.

November 17, 2020
·
10 min read
Business

Immunic, Inc. Announces Formation of Scientific-Medical Advisory Board

Initial Appointments Include Internationally Recognized Experts: Fred D. Lublin, M.D.; Bruce E. Sands, M.D., M.S.; Jerrold R. Turner, M.D., Ph.D. and Paul J. Utz, M.D.

November 17, 2020
·
11 min read
Business

Imara Announces the Appointment of Lynette Hopkinson as Senior Vice President of Regulatory

Brings 25 years of experience in the pharmaceutical and biotech industries and a deep understanding of global regulatory strategy and commercial regulatory affairs

November 17, 2020
·
4 min read
Genetown

Microbot Medical Secures Patents in Multiple Global Jurisdictions

Microbot Medical Inc. announced that it has received patents in multiple jurisdictions, further demonstrating the Company’s continued execution of expanding and protecting its Intellectual Property portfolio.

November 17, 2020
·
3 min read
Business

Cerecor to Collaborate with Frontiers CDG Consortium on Pivotal Trial of CERC-801 for the Treatment of PGM1-CDG

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced a collaboration with The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) led by Eva Morava-Kozicz, M.D. Ph.D., Principal Investigator of the trial, Professor of Medical Genetics, Senior Associate Consultant, Department of Clinical Genomics

November 17, 2020
·
7 min read
Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare Conference

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and will also participate in the Jefferies Banking Conference: 1 9 November 2020 – Dr. Christian Itin, chairman and chief executiv

November 17, 2020
·
1 min read